Signaling to p53: Ribosomal Proteins Find Their Way

被引:461
|
作者
Zhang, Yanping [1 ,2 ,3 ]
Lu, Hua [4 ,5 ]
机构
[1] Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA
[4] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA
[5] Indiana Univ Sch Med, Simon Canc Ctr, Indianapolis, IN 46202 USA
基金
美国国家卫生研究院;
关键词
UBIQUITIN LIGASE ACTIVITY; DIAMOND-BLACKFAN ANEMIA; NON-ONCOGENE ADDICTION; ZINC-FINGER DOMAIN; C-MYC; ACTIVATES P53; CELL-CYCLE; EMBRYONIC LETHALITY; ONCOPROTEIN MDM2; IN-VIVO;
D O I
10.1016/j.ccr.2009.09.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inherently disparate cell growth and division, which are intimately coupled through a delicate network of intracellular and extracellular signaling, require ribosomal biogenesis. A number of events imparting instability to ribosomal biogenesis can cause nucleolar stress. In response to this stress, several ribosomal proteins bind to MDM2 and block MDM2-mediated p53 ubiquitination and degradation, resulting in p53-dependent cell cycle arrest. By doing so, the ribosomal proteins play a crucial role in connecting deregulated cell growth with inhibition of cell division. The ribosomal protein-MDM2-p53 signaling pathway provides a molecular switch that may constitute a surveillance network monitoring the integrity of ribosomal biogenesis.
引用
收藏
页码:369 / 377
页数:9
相关论文
共 50 条
  • [31] Deciphering p53 signaling in tumor suppression
    Mello, Stephano S.
    Attardi, Laura D.
    CURRENT OPINION IN CELL BIOLOGY, 2018, 51 : 65 - 72
  • [32] p53 signaling in cancer progression and therapy
    Hany E. Marei
    Asmaa Althani
    Nahla Afifi
    Anwarul Hasan
    Thomas Caceci
    Giacomo Pozzoli
    Andrea Morrione
    Antonio Giordano
    Carlo Cenciarelli
    Cancer Cell International, 21
  • [33] Defective p53 antiangiogenic signaling in glioblastoma
    Berger, Benjamin
    Capper, David
    Lemke, Dieter
    Pfenning, Philipp-Niclas
    Platten, Michael
    Weller, Michael
    von Deimling, Andreas
    Wick, Wolfgang
    Weiler, Markus
    NEURO-ONCOLOGY, 2010, 12 (09) : 894 - 907
  • [34] Structural Evolution and Dynamics of the p53 Proteins
    Chillemi, Giovanni
    Kehrloesser, Sebastian
    Bernassola, Francesca
    Desideri, Alessandro
    Doetsch, Volker
    Levine, Arnold J.
    Melino, Gerry
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (04):
  • [35] Deciphering the significance of p53 mutant proteins
    Butera, Alessio
    Amelio, Ivano
    TRENDS IN CELL BIOLOGY, 2025, 35 (03) : 258 - 268
  • [36] INTERACTION OF ADENOVIRAL PROTEINS WITH PRB AND P53
    MORAN, E
    FASEB JOURNAL, 1993, 7 (10): : 880 - 885
  • [37] p53 Family proteins: Damage limitation
    Amelio, Ivano
    Melino, Gerry
    ELIFE, 2016, 5
  • [38] REGULATION OF P53 BY THE RIBOSOMAL PROTEIN S26
    Cui, D.
    Li, L.
    Tang, J.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2013, 40 : 18 - 18
  • [39] p53 family proteins in thyroid cancer
    Malaguarnera, R.
    Vella, V.
    Vigneri, R.
    Frasca, F.
    ENDOCRINE-RELATED CANCER, 2007, 14 (01) : 43 - 60
  • [40] Involvement of p53 in ribosomal RNA processing and translational control
    Ghayad, Sandra E.
    Belin, Stephane
    Morel, Anne-Pierre
    Hacot, Sabine
    Mertani, Hichem C.
    Vendrell, Julie
    Bourdon, Jean-Christophe
    Prats, Anne-Catherine
    Puisieux, Alain
    Diaz, Jean-Jacques
    BULLETIN DU CANCER, 2011, 98 : S30 - S30